BBIO - BridgeBio Pharma, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$105.15
DETAILS
HIGH:
$157.00
LOW:
$83.00
MEDIAN:
$100.00
CONSENSUS:
$105.15
UPSIDE:
52.13%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue | 502.1 | 221.9 | 9.3 | 77.6 | 69.7 | 8.2 | 40.6 | 0 | 0 |
| Cost of Revenue | 28.3 | 3.9 | 2.4 | 3.4 | 3.1 | 0 | 2.5 | 0 | 0.3 |
| Gross Profit | 473.8 | 218.0 | 6.9 | 74.2 | 66.6 | 8.2 | 38.1 | 0 | (0.3) |
| Operating Expenses | |||||||||
| R&D Expenses | 477.5 | 506.5 | 455.7 | 399.5 | 451.0 | 337.0 | 209.9 | 140.1 | 30.6 |
| SG&A Expenses | 555.1 | 288.9 | 150.6 | 143.2 | 192.2 | 145.7 | 94.4 | 43.6 | 13.3 |
| Other Expenses | 10.2 | 15.6 | 7.9 | 43.8 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 1,042.9 | 811.0 | 614.2 | 586.4 | 643.2 | 482.7 | 304.3 | 183.7 | 43.9 |
| Operating Income | |||||||||
| Operating Income | (569.1) | (593.0) | (607.4) | (512.2) | (576.6) | (474.5) | (266.2) | (183.7) | (43.9) |
| Interest Expense | 53.1 | 99.3 | 81.3 | 80.4 | 46.8 | 36.7 | 8.8 | 2.5 | 0.0 |
| Interest Income | 19.9 | 17.2 | 18.0 | 7.5 | 1.1 | 4.0 | 8.9 | 2.0 | 0.0 |
| Profitability | |||||||||
| EBITDA | (672.9) | (436.8) | (565.5) | (397.4) | (533.8) | (467.4) | (279.0) | (183.4) | (43.6) |
| EBIT | (681.9) | (442.9) | (572.0) | (404.2) | (539.7) | (468.8) | (279.8) | (183.7) | (43.8) |
| Income Before Tax | (735.0) | (542.2) | (653.3) | (484.7) | (586.5) | (505.5) | (288.6) | (169.5) | (43.8) |
| Income Tax Expense | 0.6 | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (729.3) | (535.8) | (643.2) | (481.2) | (562.5) | (448.7) | (260.4) | (130.7) | (30.6) |
| Per Share Data | |||||||||
| EPS (Basic) | -3.79 | -2.88 | -3.95 | -3.35 | -3.90 | -4.10 | -2.48 | -1.42 | -0.33 |
| EPS (Diluted) | -3.79 | -2.88 | -3.95 | -3.35 | -3.90 | -4.10 | -2.48 | -1.42 | -0.33 |
| Shares Outstanding | 197.2 | 186.1 | 162.8 | 147.5 | 144.4 | 118.0 | 105.1 | 92.3 | 92.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | 570.1 | 681.1 | 375.9 | 376.7 | 393.8 | 356.1 | 363.8 | 436.1 | 92.0 |
| Short-Term Investments | 17.4 | 0 | 58.9 | 95.2 | 442.9 | 251.0 | 182.2 | 0 | 0 |
| Net Receivables | 139.4 | 4.7 | 1.8 | 17.1 | 19.7 | 0 | 2.8 | 0 | 0 |
| Inventory | 26.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 3.8 | 27.7 | 37.9 | 0.2 | 0.1 | 0 | 0 | 0.9 |
| Total Current Assets | 753.7 | 720.7 | 477.6 | 548.9 | 888.9 | 642.8 | 568.6 | 445.2 | 97.1 |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment | 13.5 | 12.8 | 19.8 | 25.2 | 46.0 | 36.8 | 5.6 | 1.6 | 0.4 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 28.1 | 23.9 | 26.3 | 28.7 | 44.9 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 81.4 | 143.7 | 0 | 0 | 0 | 0 | 31.1 | 17.1 | 0.4 |
| Other Non-Current Assets | (81.4) | 18.2 | 22.6 | 20.2 | 33.0 | 23.9 | 26.3 | 1.1 | 0.1 |
| Total Non-Current Assets | 41.6 | 198.6 | 68.8 | 74.2 | 123.9 | 60.8 | 63.1 | 19.7 | 0.9 |
| Total Assets | 936.0 | 919.3 | 546.4 | 623.0 | 1,012.8 | 703.6 | 631.7 | 464.9 | 98.0 |
| Current Liabilities | |||||||||
| Account Payables | 36.2 | 9.6 | 10.7 | 11.6 | 11.9 | 8.9 | 8.9 | 13.5 | 1.9 |
| Short-Term Debt | 17.4 | 0 | 0 | 0 | 0 | 1.5 | 0 | 0 | 0 |
| Deferred Revenue | 20.3 | 0 | 6.1 | 8.2 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 214.1 | 16.2 | 65.6 | 31.3 | 37.0 | 9.6 | 25.4 | 4.0 | 1.0 |
| Total Current Liabilities | 288.0 | 154.4 | 143.8 | 121.4 | 135.1 | 95.6 | 60.4 | 32.6 | 8.6 |
| Non-Current Liabilities | |||||||||
| Long-Term Debt | 2,707.5 | 1,721.4 | 1,726.7 | 1,707.6 | 1,703.8 | 475.9 | 91.8 | 54.5 | 143.9 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0.2 | 496.5 | 9.4 | 26.6 | 22.1 | 9.5 | 3.5 | 479.4 | 0.3 |
| Total Non-Current Liabilities | 2,724.6 | 2,222.6 | 1,745.1 | 1,746.5 | 1,743.3 | 500.1 | 95.3 | 533.9 | 144.2 |
| Total Liabilities | 3,012.6 | 2,376.9 | 1,888.9 | 1,868.0 | 1,878.4 | 595.7 | 155.7 | 566.4 | 152.7 |
| Stockholders' Equity | |||||||||
| Common Stock | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 6.6 | 3.4 |
| Retained Earnings | (3,821.2) | (3,096.3) | (2,560.5) | (1,918.1) | (1,437.0) | (888.8) | (440.0) | (170.6) | (61.4) |
| Accumulated Other Comprehensive Income | 0.0 | 0.0 | 0.0 | (0.3) | (0.1) | 0.2 | 0.3 | (0.2) | (0.0) |
| Total Stockholders' Equity | (2,076.6) | (1,467.9) | (1,354.3) | (1,254.6) | (870.4) | 57.9 | 408.5 | (164.0) | (58.0) |
| Total Liabilities & Equity | 936.0 | 919.3 | 546.4 | 623.0 | 1,012.8 | 703.6 | 631.7 | 464.9 | 98.0 |
| Debt Metrics | |||||||||
| Total Debt | 2,728.7 | 1,730.6 | 1,739.8 | 1,723.6 | 1,726.2 | 495.8 | 91.8 | 54.5 | 143.9 |
| Net Debt | 2,158.6 | 1,049.5 | 1,363.9 | 1,346.9 | 1,332.4 | 139.7 | (272.0) | (381.6) | 51.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | (724.9) | (543.3) | (643.2) | (484.7) | (586.5) | (505.5) | (288.6) | (169.5) | (43.8) |
| Depreciation & Amortization | 6.0 | 6.1 | 6.5 | 6.8 | 5.8 | 3.1 | 0.9 | 0.2 | 0.3 |
| Stock-Based Compensation | 133.0 | 95.8 | 0 | 91.6 | 99.5 | 58.5 | 21.4 | 6.1 | 1.8 |
| Change in Working Capital | (51.1) | 32.0 | 5.1 | 28.1 | (4.4) | 14.9 | (10.9) | 22.5 | 1.2 |
| Other Non-Cash Items | 191.1 | (111.3) | 103.9 | (61.3) | 18.5 | 31.2 | 24.5 | 18.9 | 0.3 |
| Operating Cash Flow | (445.9) | (520.7) | (527.7) | (419.5) | (497.9) | (399.7) | (253.6) | (136.6) | (40.5) |
| Investing Activities | |||||||||
| Capital Expenditure | (1.1) | (0.9) | (1.3) | (6.3) | (48.2) | (7.5) | (5.1) | (18.2) | (0.5) |
| Acquisitions | 0 | (0.1) | 0 | 0 | (35) | 21.2 | (5.5) | (2.9) | 2.8 |
| Purchases of Investments | (28.2) | (88.4) | (137.3) | (193.1) | (643.3) | (287.9) | (212.9) | 0 | 0 |
| Sales/Maturities of Investments | 11 | 158.2 | 193.1 | 532.5 | 477.0 | 242.2 | 5.5 | 0 | 0 |
| Other Investing Activities | (6.2) | (8.0) | (0.5) | 118.5 | 48.7 | (21.1) | 0.8 | (2.9) | 0 |
| Investing Cash Flow | (24.5) | 60.8 | 54.0 | 453.1 | (200.8) | (53.0) | (217.3) | (21.0) | (0.5) |
| Financing Activities | |||||||||
| Net Debt Issuance | 385.5 | 476.6 | 0 | (20.5) | 1,079.7 | 550 | 36.9 | 56.4 | 4.1 |
| Stock Repurchased | (48.3) | (7.5) | (6.9) | (1.6) | (204.7) | (75.7) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | (1.0) | 0 | (1.2) |
| Other Financing Activities | (12.1) | (35.3) | 8.6 | 4.1 | (138.5) | (27.1) | (4.4) | 14.6 | 1.8 |
| Financing Cash Flow | 359.3 | 748.5 | 451.5 | (13.1) | 736.4 | 447.2 | 398.8 | 501.5 | 113.0 |
| Cash Position | |||||||||
| Net Change in Cash | (111.1) | 288.5 | (22.2) | 20.5 | 37.7 | (5.5) | (72.0) | 343.9 | 72.0 |
| Cash at Beginning | 683.2 | 394.7 | 416.9 | 396.4 | 358.7 | 364.2 | 436.2 | 92.4 | 20.3 |
| Cash at End | 572.1 | 683.2 | 394.7 | 416.9 | 396.4 | 358.7 | 364.2 | 436.2 | 92.4 |
| Free Cash Flow | (447.0) | (521.7) | (529.0) | (425.8) | (546.2) | (407.2) | (258.7) | (154.8) | (41.0) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 502.1 | 221.9 | 9.3 | 77.6 | 69.7 | 8.2 | 40.6 | 0 | 0 |
| Gross Profit | 473.8 | 218.0 | 6.9 | 74.2 | 66.6 | 8.2 | 38.1 | 0 | (0.3) |
| Operating Income | (569.1) | (593.0) | (607.4) | (512.2) | (576.6) | (474.5) | (266.2) | (183.7) | (43.9) |
| Net Income | (729.3) | (535.8) | (643.2) | (481.2) | (562.5) | (448.7) | (260.4) | (130.7) | (30.6) |
| EPS (Diluted) | -3.79 | -2.88 | -3.95 | -3.35 | -3.90 | -4.10 | -2.48 | -1.42 | -0.33 |
| Balance Sheet | |||||||||
| Cash & Equivalents | 570.1 | 681.1 | 375.9 | 376.7 | 393.8 | 356.1 | 363.8 | 436.1 | 92.0 |
| Total Assets | 936.0 | 919.3 | 546.4 | 623.0 | 1,012.8 | 703.6 | 631.7 | 464.9 | 98.0 |
| Total Debt | 2,728.7 | 1,730.6 | 1,739.8 | 1,723.6 | 1,726.2 | 495.8 | 91.8 | 54.5 | 143.9 |
| Stockholders' Equity | (2,076.6) | (1,467.9) | (1,354.3) | (1,254.6) | (870.4) | 57.9 | 408.5 | (164.0) | (58.0) |
| Cash Flow | |||||||||
| Operating Cash Flow | (445.9) | (520.7) | (527.7) | (419.5) | (497.9) | (399.7) | (253.6) | (136.6) | (40.5) |
| Capital Expenditure | (1.1) | (0.9) | (1.3) | (6.3) | (48.2) | (7.5) | (5.1) | (18.2) | (0.5) |
| Free Cash Flow | (447.0) | (521.7) | (529.0) | (425.8) | (546.2) | (407.2) | (258.7) | (154.8) | (41.0) |